| DIRECT COMPETITOR COMPARISON | |
| XNPT | ABT | AZN | PFE | Industry | | Market Cap: | 496.06M | 83.52B | 67.24B | 147.67B | 98.96M | | Employees: | 222 | 72,000 | 65,000 | 81,800 | 68 | | Qtrly Rev Growth (yoy): | 0.00% | 3.50% | 5.50% | -2.90% | 19.70% | | Revenue (ttm): | 39.50M | 29.92B | 32.05B | 45.82B | 14.01M | | Gross Margin (ttm): | -82.75% | 58.31% | 82.24% | 86.61% | 65.67% | | EBITDA (ttm): | -64.69M | 8.64B | 13.52B | 21.31B | -12.30M | | Oper Margins (ttm): | -172.74% | 22.32% | 37.85% | 37.42% | -137.11% | | Net Income (ttm): | -66.71M | 5.60B | 7.22B | 8.09B | N/A | | EPS (ttm): | -2.426 | 3.691 | 4.98 | 1.204 | -0.33 | | P/E (ttm): | N/A | 14.63 | 9.31 | 15.20 | 17.26 | | PEG (5 yr expected): | N/A | 1.27 | N/A | 5.95 | 1.28 | | P/S (ttm): | 12.55 | 2.78 | 2.09 | 3.26 | 9.45 |
|
| ABT = Abbott Laboratories | | AZN = AstraZeneca plc | | PFE = Pfizer Inc. | | Industry = Biotechnology | |
| BIOTECHNOLOGY COMPANIES RANKED BY SALES | |
|
| Company | Symbol | Price | Change | Market Cap | P/E | | Amgen Inc. | AMGN | 56.47 | -0.67% | 57.16B | 12.32 | | Genentech, Inc. | Private - View Profile | | Biogen Idec Inc. | BIIB | 48.2301 | 0.10% | 13.95B | 16.14 | | Genzyme Corp. | GENZ | 49.92 | -0.12% | 13.25B | 28.46 | | Merck Serono S.A. | Private - View Profile | | Chiron Corporation | Private - View Profile | | Gilead Sciences Inc. | GILD | 46.75 | 0.34% | 42.07B | 18.08 | | MedImmune, Inc. | Private - View Profile | | Life Technologies Corporation | LIFE | 50.4403 | -0.39% | 9.00B | 1029.39 | | Teva Pharmaceutical Industries Limited | TEVA | 53.67 | -0.63% | 47.28B | 49.10 |
|
| GENERIC DRUGMAKERS RANKED BY SALES | |
|
| Company | Symbol | Price | Change | Market Cap | P/E | | Sandoz International GmbH | Private - View Profile | | Watson Pharmaceuticals Inc. | WPI | 38.1725 | 0.72% | 4.05B | 19.68 | | King Pharmaceuticals Inc. | KG | 11.60 | -1.02% | 2.88B | N/A | | Ranbaxy Laboratories Limited | Private - View Profile | | Mylan, Inc. | MYL | 18.3475 | 1.99% | 5.61B | 112.56 | | Pfizer Inc. | PFE | 18.299999 | -1.03% | 147.67B | 15.20 | | Johnson & Johnson | JNJ | 64.30 | -0.09% | 177.41B | 14.04 | | GlaxoSmithKline plc | GSK | 42.75 | 0.00% | 108.37B | 13.49 | | Sanofi-Aventis | SNY | 38.94 | -1.12% | 101.68B | N/A | | Novartis AG | NVS | 55.69 | 0.25% | 126.48B | 16.67 |
|
| DRUGMAKERS RANKED BY SALES | |
|
| Company | Symbol | Price | Change | Market Cap | P/E | | RHHBY.PK | 41.34 | -0.19% | N/A | N/A | | AstraZeneca plc | AZN | 46.369 | 0.15% | 67.24B | 9.31 | | Abbott Laboratories | ABT | 54.00 | 0.41% | 83.52B | 14.63 | | Bristol-Myers Squibb Co. | BMY | 25.50 | 1.43% | 50.51B | 13.19 |
|
| NEWS ON DIRECT COMPETITORS | |
| • | AZN | | Bristol Seeks EU OK for Apixaban
Mon 10:06am -
Zacks.com | | • | ABT | | Jeff Saut: Will the Upside Continue Into Year-End?
Mon 10:00am -
at Minyanville.com | | • | ABT | | Sanford Bernstein Sees Gain For Generics Under Health Care Reform Bill Resulting In Margin Expansion For PBMs
Mon 8:06am -
Wall Street Transcript | | • | PFE | | Moment of Truth for Health Care
Mon 6:00am -
Morningstar.com | | • | PFE | | UPDATE - Bayer, J&J take more time in bid to convince FDA
Sun 6:09pm -
at Reuters | | • | AZN | | Blood Thinner Battle Heats Up
Sun 1:36pm -
at Forbes.com | | • | PFE | | [video] Stocks Under $10: 2 Potential Buys
Sun 12:00pm -
at TheStreet.com | | • | PFE | | [video] Stocks Under $10: Two Buys
Sun 12:00pm -
at TheStreet.com | | • | AZN | | Astra-Zeneca Flies to JUPITER on Drug Results
Sun 9:04am -
at Seeking Alpha | | • | AZN | | [$$] Seroquel XR Gets New FDA Approval
Fri, Dec 4 -
at The Wall Street Journal Online | | • | AZN | | Week Ahead: Road Upward for Stocks Is Getting Rougher
Fri, Dec 4 -
at CNBC | | • | AZN | | Antipsychotics, Diabetes & Kids
Fri, Dec 4 -
at The Wall Street Journal Online | | • | AZN | | Baxter Receives H1N1 Vaccine Order
Fri, Dec 4 -
Zacks.com | | • | AZN | | Significant Deal for AZN
Fri, Dec 4 -
Zacks.com | | • | ABT | | Prospecting for Stocks: Oculus Innovative Sciences
Fri, Dec 4 -
at Motley Fool | | • | AZN | | After Rising 500%, What Did You Expect?
Fri, Dec 4 -
at Motley Fool | | • | AZN | | FDA Panel Recommends Antipsychotic-Drug Review of Kids' Weight Gain
Fri, Dec 4 -
at The Wall Street Journal Online | | • | AZN | | Biotech Stocks: Euro drugmakers lead sector stocks higher
Fri, Dec 4 -
at MarketWatch | | • | ABT | | Consumer advocate asks FDA to ban weight loss pill
Thu, Dec 3 -
AP | | • | ABT | | UPDATE - US consumer group asks FDA to ban Abbott diet drug
Thu, Dec 3 -
at Reuters | | | All Headlines for these symbols... |
|
|
|
0.29% Nasdaq 
Competitors
